Wheatley Sean D, Deakin Trudi A, Arjomandkhah Nicola C, Hollinrake Paul B, Reeves Trudi E
X-PERT Health, Hebden Bridge, United Kingdom.
School of Social and Health Sciences, Leeds Trinity University, Leeds, United Kingdom.
Front Nutr. 2021 Jul 15;8:687658. doi: 10.3389/fnut.2021.687658. eCollection 2021.
Although carbohydrate restriction is not a new approach for the management of Type 2 diabetes, interest in its safety and efficacy has increased significantly in recent years. The purpose of the current narrative review is to summarise the key relevant research and practical considerations in this area, as well as to explore some of the common concerns expressed in relation to the use of such approaches. There is a strong physiological rationale supporting the role of carbohydrate restriction for the management of Type 2 diabetes, and available evidence suggests that low carbohydrate dietary approaches (LCDs) are as effective as, or superior to, other dietary approaches for its management. Importantly, LCDs appear to be more effective than other dietary approaches for facilitating a reduction in the requirement for certain medications, which leads to their effects on other health markers being underestimated. LCDs have also been demonstrated to be an effective method for achieving remission of Type 2 diabetes for some people. The available evidence does not support concerns that LCDs increase the risk of cardiovascular disease, that such approaches increase the risk of nutrient deficiencies, or that they are more difficult to adhere to than other dietary approaches. A growing number of organisations support the use of LCDs as a suitable choice for individuals with Type 2 diabetes.
尽管限制碳水化合物摄入并非治疗2型糖尿病的新方法,但近年来人们对其安全性和有效性的关注度显著提高。本叙述性综述的目的是总结该领域的关键相关研究和实际考量因素,并探讨与使用此类方法相关的一些常见担忧。有充分的生理学依据支持限制碳水化合物摄入在2型糖尿病管理中的作用,现有证据表明,低碳水化合物饮食方法(LCDs)在管理2型糖尿病方面与其他饮食方法一样有效,甚至更优。重要的是,LCDs在促进减少某些药物需求方面似乎比其他饮食方法更有效,这导致其对其他健康指标的影响被低估。对于一些人来说,LCDs也已被证明是实现2型糖尿病缓解的有效方法。现有证据并不支持以下担忧:LCDs会增加心血管疾病风险、此类方法会增加营养缺乏风险,或者它们比其他饮食方法更难坚持。越来越多的组织支持将LCDs作为2型糖尿病患者的合适选择。